P12.02 Adaptor P329G-directed CAR T cells for modular targeting of AML

• C Klein,
• S Stock,
• S Endres,
• S Kobold,
• M Subklewe,
• M von Bergwelt-Baildon,
• A Gottschlich,
• L Rohrbacher,
• D Darowski,
• T Strzalkowski,
• L Fertig,
• VD Menkhoff,
• M Surowka,
• P Bruenker

Affiliations

C Klein

3Roche innovation center Zurich, Schlieren, Switzerland

S Stock

1Division of Clinical Pharmacology, Department of Medicine IV, University Hospital, Ludwig Maximilian University (LMU) of Munich, Munich, Germany

S Endres

Aff1 Division of Clinical Pharmacology Munich Germany

S Kobold

Aff1 Division of Clinical Pharmacology Munich Germany

M Subklewe

Aff3 grid.411095.80000000404772585Department of Internal Medicine IIIKlinikum der Universität München Munich Germany

M von Bergwelt-Baildon

Aff2 grid.411097.a000000008852305XDepartment I of Internal Medicine and Cologne Interventional ImmunologyUniversity Hospital Cologne Cologne Germany

A Gottschlich

1Division of Clinical Pharmacology, Munich, Germany

L Rohrbacher

4Department of Medicine III, University Hospital, LMU Munich, Munich, Germany

D Darowski

5Roche Innovation Center Zurich, Roche Pharma Research and Early Development, Schlieren, Switzerland

T Strzalkowski

1Division of Clinical Pharmacology, LMU University Hospital, LMU Munich, Munich, Germany

L Fertig

1Division of Clinical Pharmacology, LMU University Hospital, LMU Munich, Munich, Germany

VD Menkhoff

1Division of Clinical Pharmacology, LMU University Hospital, LMU Munich, Munich, Germany

M Surowka

5Roche Innovation Center Zurich, Roche Pharma Research and Early Development, Schlieren, Switzerland

P Bruenker

5Roche Innovation Center Zurich, Roche Pharma Research and Early Development, Schlieren, Switzerland